BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11064564)

  • 1. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
    Rodríguez P; Romero T; Rodríguez de Castro F; Hussein M; Freixinet J
    Rheumatology (Oxford); 2006 Mar; 45(3):359-60. PubMed ID: 16436491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Positron emission tomography of the thorax. The current clinical status].
    Knopp MV; Bischoff H; Oberdorfer F; van Kaick G
    Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of 18F-FDG positron emission tomography in surgical evaluation].
    Franzius C; Sciuk J; Schober O
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():261-9. PubMed ID: 9931622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma.
    M Herder GJ; Welling A; De Winter GV; Comans EF; Hoekstra OS
    Clin Nucl Med; 2003 Jan; 28(1):58-9. PubMed ID: 12493968
    [No Abstract]   [Full Text] [Related]  

  • 7. [A colon adenocarcinoma and a pharyngeal carcinoma incidentally detected by means of (18)F-FDG PET in a patient diagnosed of lung cancer].
    Caballero Gullón L; Borrego Dorado I; Vázquez Albertino R
    Rev Esp Med Nucl; 2010; 29(1):29-31. PubMed ID: 19969392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of synchronous adenocarcinomas and multiple dysplastic polyps with F-18 FDG positron emission tomography in a case of nonfamilial polyposis.
    Patrikeos AP; Mackay JR; Hicks RJ
    Clin Nucl Med; 2003 Jun; 28(6):487-8. PubMed ID: 12917531
    [No Abstract]   [Full Text] [Related]  

  • 9. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN
    Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenomyomatosis of the gallbladder: another cause for a "hot" gallbladder on 18F-FDG PET.
    Maldjian PD; Ghesani N; Ahmed S; Liu Y
    AJR Am J Roentgenol; 2007 Jul; 189(1):W36-8. PubMed ID: 17579133
    [No Abstract]   [Full Text] [Related]  

  • 12. 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.
    Patz EF
    Radiographics; 2000; 20(4):1182-5. PubMed ID: 10903708
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.
    Ahuja V; Coleman RE; Herndon J; Patz EF
    Cancer; 1998 Sep; 83(5):918-24. PubMed ID: 9731895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
    Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in lung cancer.
    Lowe VJ; Naunheim KS
    Ann Thorac Surg; 1998 Jun; 65(6):1821-9. PubMed ID: 9647121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis.
    Muñoz MA; Conejo-Mir JS; Congregado-Loscertales M; Holgado C; Moya F; Loscertales J
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1418-9. PubMed ID: 17958854
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thallium and FDG uptake by atelectasis with bronchogenic carcinoma.
    Kawabe J; Okamura T; Shakudo M; Koyama K; Wanibuchi H; Shimonishi Y; Ochi H; Yamada R
    Ann Nucl Med; 1999 Aug; 13(4):273-6. PubMed ID: 10510886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
    Barghouth G; Allaoua M; Goerres GW
    Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma].
    Ukena D; Hellwig D; Palm I; Rentz K; Leutz M; Hellwig AP; Kirsch CM; Sybrecht GW
    Pneumologie; 2000 Feb; 54(2):49-53. PubMed ID: 10731756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.